Description
Delta sleep-inducing peptide (DSIP) is an experimental neuropeptide studied for its potential to support deep sleep, manage stress, and modulate pain, though 5mg is a massive amount compared to standard research doses and the compound lacks regulatory approval.
Potential Benefits Explored in Research
- Sleep Regulation: Studies suggest DSIP may promote slow-wave (delta) sleep and help normalize rest patterns without traditional pharmacological sedation.
- Stress and Cortisol Control: Research indicates it may influence the hypothalamic-pituitary-adrenal (HPA) axis to reduce stress-related hormonal fluctuations.
- Pain Modulation: Early clinical and animal observations point to potential analgesic properties and a reduction in certain chronic pain states.
Important Safety and Dosage Context
- Dosing Discrepancy: Traditional scientific research protocols typically evaluated microgram doses (such as 100mcg or calculated nmol/kg body weight), meaning a 5mg vial represents a massive quantity that far exceeds standard investigative frameworks.
- Lack of Approval: DSIP is not approved by regulatory bodies like the FDA for treating insomnia or any medical condition.
- Limited Human Data: Most supporting evidence comes from older, small-scale human studies or animal models, and long-term safety profiles remain unknown. Potential side effects include dizziness, headaches, and injection site irritation.
-
Is it legal to buy in South Africa?
It is not a SAHPRA-registered medicine. All three actives fall under South Africa’s medicines-scheduling framework, and Ignite Muscles supplies it for research and educational purposes only. Any personal use should be discussed with a registered SA practitioner.
-
Reviews
There are no reviews yet.